Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02124980 · ClinicalTrials.gov registry record · NA
Automated Recovery Line for Medication Assisted Treatment
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02124980 is a NA study that has completed, run by Yale University. The registered enrollment target is 60 participants.
The verdict
NCT02124980, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
If shown to be effective, the Recovery Line would provide an inexpensive, transportable, and easy to use treatment to improve substance abuse outcomes for medication assisted treatment. Given the high costs of relapse and continued drug use, improvement of treatment outcomes would provide substantial health, economic, and societal benefits.
Interventions
- BEHAVIORAL Recovery Line
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02124980
The ClinicalTrials.gov registry entry for NCT02124980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Recovery Line is the first listed.
NCT02124980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02124980 about?
NCT02124980 is a clinical study titled "Automated Recovery Line for Medication Assisted Treatment". If shown to be effective, the Recovery Line would provide an inexpensive, transportable, and easy to use treatment to improve substance abuse outcomes for medication assisted treatment. Given the high costs of relapse and continued drug use, improvement of treatment outcomes would provide substantia...
What is the current status of trial NCT02124980?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-11. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02124980?
The interventions under investigation include: Recovery Line (BEHAVIORAL).
Who is sponsoring clinical trial NCT02124980?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.